John Marioni elected to EMBO Membership
Senior Group Leader, Dr John Marioni, has been elected a member of the European Molecular Biology Organisation (EMBO) in recognition of his high-quality life science research.
Marioni is one of 64 life scientists that have been elected to EMBO membership this year, joining a community of more than 1,800 leading life scientists.
EMBO Members are actively involved in the organisation. They serve on EMBO Council, Committees, and Advisory Editorial Boards of EMBO Press journals, evaluate applications for EMBO funding, and mentor early-career scientists. Collectively, they can influence the direction of the life sciences in Europe and beyond.
“I am delighted to welcome the new members into our organisation and look forward to working with them,” says EMBO Director Maria Leptin. “An election to the EMBO Membership recognises outstanding achievements in the life sciences. The new members will provide expertise and guidance that will help EMBO to further strengthen its initiatives.”
New members are nominated and elected by the existing EMBO Membership; it is not possible to apply to become a member. One election is held each year. The new EMBO Members will be formally welcomed at the annual EMBO Members’ Meeting between 27 and 29 October 2021.
Related News
See all news-
1M to advance AI powered personalised ovarian cancer care
19th February 2026
Researchers from our Brenton Group are part of an international team awarded the Global Ovarian Cancer Research Consortium’s inaugural AI Accelerator Grant.
Find out more -
Professor Sir Steve Jackson elected as a fellow of the American Association for Cancer Research
16th February 2026
Senior Group Leader Sir Steve Jackson has been elected as a Fellow of the American Association for Cancer Research Academy in the Class of 2026.
Find out more -
New immune pathway offers treatment hope for childhood brain tumours
3rd February 2026
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more